Structure and design of Langya virus glycoprotein antigens

Langya virus (LayV) is a recently discovered henipavirus (HNV), isolated from febrile patients in China. HNV entry into host cells is mediated by the attachment (G) and fusion (F) glycoproteins which are the main targets of neutralizing antibodies. We show here that the LayV F and G glycoproteins promote membrane fusion with human, mouse and hamster target cells using a different, yet unknown, receptor than NiV and HeV and that NiV-and HeV-elicited monoclonal and polyclonal antibodies do not cross-react with LayV F and G. We determined cryo-electron microscopy structures of LayV F, in the prefusion and postfusion states, and of LayV G, revealing previously unknown conformational landscapes and their distinct antigenicity relative to NiV and HeV. We computationally designed stabilized LayV G constructs and demonstrate the generalizability of an HNV F prefusion-stabilization strategy. Our data will support the development of vaccines and therapeutics against LayV and closely related HNVs.

[1]  David J. Fleet,et al.  3D Flexible Refinement: Determining Structure and Motion of Flexible Proteins from Cryo-EM. , 2023, Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada.

[2]  Cassandra L. Pegg,et al.  Structure and antigenicity of divergent Henipavirus fusion glycoproteins , 2023, Nature communications.

[3]  L. Käll,et al.  Automated model building and protein identification in cryo-EM maps , 2023, bioRxiv.

[4]  P. Acharya,et al.  Structures of Langya Virus Fusion Protein Ectodomain in Pre- and Postfusion Conformation , 2023, bioRxiv.

[5]  David J. Fleet,et al.  3DFlex: determining structure and motion of flexible proteins from cryo-EM , 2023, Nature Methods.

[6]  S. Madhi,et al.  Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. , 2023, The New England journal of medicine.

[7]  E. Walsh,et al.  Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. , 2023, The New England journal of medicine.

[8]  L. M. Casseb,et al.  First Genomic Evidence of a Henipa-like Virus in Brazil , 2022, Viruses.

[9]  Yue Li,et al.  A Zoonotic Henipavirus in Febrile Patients in China. , 2022, The New England journal of medicine.

[10]  J. Derisi,et al.  Discovery and Genomic Characterization of a Novel Henipavirus, Angavokely virus, from fruit bats in Madagascar , 2022, bioRxiv.

[11]  B. Sankaran,et al.  Robust deep learning based protein sequence design using ProteinMPNN , 2022, bioRxiv.

[12]  C. Broder,et al.  Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Noam Brown,et al.  Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia , 2022, Emerging infectious diseases.

[14]  C. Broder,et al.  Architecture and antigenicity of the nipah virus attachment glycoprotein , 2022, Biophysical Journal.

[15]  T. Klein,et al.  Discovery and Genetic Characterization of Novel Paramyxoviruses Related to the Genus Henipavirus in Crocidura Species in the Republic of Korea , 2021, Viruses.

[16]  C. Broder,et al.  Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein , 2021, Cell reports.

[17]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[18]  David T. Williams,et al.  A new Hendra virus genotype found in Australian flying foxes , 2021, Virology Journal.

[19]  C. Broder,et al.  Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins , 2021, Nature Structural & Molecular Biology.

[20]  J. Epstein,et al.  Functional Analysis of the Fusion and Attachment Glycoproteins of Mojiang Henipavirus , 2021, Viruses.

[21]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[22]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[23]  J. Crowe,et al.  Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein , 2020, Cell.

[24]  Lisa E. Gralinski,et al.  Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Walls, Fiala et al. , 2020 .

[25]  C. Broder,et al.  Vaccines to Emerging Viruses: Nipah and Hendra. , 2020, Annual review of virology.

[26]  Rebecca J. Loomis,et al.  SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness , 2020, Nature.

[27]  J. Mascola,et al.  Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development , 2020, Frontiers in Immunology.

[28]  Benjamin S. Hughes,et al.  Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. , 2020, The Lancet. Infectious diseases.

[29]  David J. Fleet,et al.  Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction , 2019, Nature Methods.

[30]  C. Broder,et al.  Optimization and Diagnostic Evaluation of Monoclonal Antibody-based Blocking ELISA Formats for Detection of Neutralizing Antibodies to Hendra Virus in Mammalian Sera. , 2019, Journal of virological methods.

[31]  Sergei L. Kosakovsky Pond,et al.  A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex , 2019, Proceedings of the National Academy of Sciences.

[32]  Paul Emsley,et al.  Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic Data , 2019, Protein science : a publication of the Protein Society.

[33]  C. Broder,et al.  A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection , 2019, The Journal of infectious diseases.

[34]  Sjors H.W. Scheres,et al.  Faculty Opinions recommendation of Real-time cryo-electron microscopy data preprocessing with Warp. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[35]  Christopher J. Williams,et al.  Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix , 2019, Acta crystallographica. Section D, Structural biology.

[36]  C. Broder,et al.  An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections , 2019, Nature Structural & Molecular Biology.

[37]  C. Broder,et al.  Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus , 2019, Proceedings of the National Academy of Sciences.

[38]  I. Rissanen,et al.  A key region of molecular specificity orchestrates unique ephrin-B1 utilization by Cedar virus , 2019, Life Science Alliance.

[39]  A. Walls,et al.  Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion , 2019, Cell.

[40]  Erik Lindahl,et al.  New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.

[41]  Jared Adolf-Bryfogle,et al.  Automatically Fixing Errors in Glycoprotein Structures with Rosetta , 2018, Structure.

[42]  Jasenko Zivanov,et al.  A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis , 2018, bioRxiv.

[43]  D. Mastronarde Advanced Data Acquisition From Electron Microscopes With SerialEM , 2018, Microscopy and Microanalysis.

[44]  Tristan Ian Croll,et al.  ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps , 2018, Acta crystallographica. Section D, Structural biology.

[45]  Conrad C. Huang,et al.  UCSF ChimeraX: Meeting modern challenges in visualization and analysis , 2018, Protein science : a publication of the Protein Society.

[46]  A. Walls,et al.  Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion , 2017, Proceedings of the National Academy of Sciences.

[47]  Barney S. Graham,et al.  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.

[48]  I. Rissanen,et al.  Idiosyncratic Mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses , 2017, Nature Communications.

[49]  David J. Fleet,et al.  cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.

[50]  Frank DiMaio,et al.  Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta , 2016, bioRxiv.

[51]  F. Dimaio,et al.  Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer , 2016, Nature.

[52]  R. Lamb,et al.  Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form , 2015, Proceedings of the National Academy of Sciences.

[53]  C. Broder,et al.  Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly , 2015, PLoS pathogens.

[54]  Keith S Wilson,et al.  Privateer: software for the conformational validation of carbohydrate structures , 2015, Nature Structural &Molecular Biology.

[55]  R. Cattaneo,et al.  A Structurally Unresolved Head Segment of Defined Length Favors Proper Measles Virus Hemagglutinin Tetramerization and Efficient Membrane Fusion Triggering , 2015, Journal of Virology.

[56]  A. Zeltiña,et al.  Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus , 2015, Proceedings of the National Academy of Sciences.

[57]  Matthias J. Brunner,et al.  Atomic accuracy models from 4.5 Å cryo-electron microscopy data with density-guided iterative local refinement , 2015, Nature Methods.

[58]  Lori A. Passmore,et al.  Ultrastable gold substrates for electron cryomicroscopy , 2014, Science.

[59]  P. Daszak,et al.  Evidence for henipavirus spillover into human populations in Africa , 2014, Nature Communications.

[60]  C. Broder,et al.  Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody , 2014, Science Translational Medicine.

[61]  Q. Jin,et al.  Novel Henipa-like Virus, Mojiang Paramyxovirus, in Rats, China, 2012 , 2014, Emerging infectious diseases.

[62]  C. Broder,et al.  Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health , 2014, Emerging infectious diseases.

[63]  C. Broder,et al.  A Recombinant Hendra Virus G Glycoprotein Subunit Vaccine Protects Nonhuman Primates against Hendra Virus Challenge , 2014, Journal of Virology.

[64]  R. Henderson,et al.  High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy☆ , 2013, Ultramicroscopy.

[65]  Cinque S. Soto,et al.  Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus , 2013, Science.

[66]  U. Baxa,et al.  Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody , 2013, Science.

[67]  R. Lamb,et al.  Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein , 2012, Proceedings of the National Academy of Sciences.

[68]  C. Broder,et al.  Biochemical, Conformational, and Immunogenic Analysis of Soluble Trimeric Forms of Henipavirus Fusion Glycoproteins , 2012, Journal of Virology.

[69]  A. Huang,et al.  N-Glycans on the Nipah Virus Attachment Glycoprotein Modulate Fusion and Viral Entry as They Protect against Antibody Neutralization , 2012, Journal of Virology.

[70]  Heinz Feldmann,et al.  A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge , 2012, Science Translational Medicine.

[71]  C. D. de Jong,et al.  Cedar Virus: A Novel Henipavirus Isolated from Australian Bats , 2012, PLoS pathogens.

[72]  Oscar A. Negrete,et al.  Cysteines in the Stalk of the Nipah Virus G Glycoprotein Are Located in a Distinct Subdomain Critical for Fusion Activation , 2012, Journal of Virology.

[73]  C. Broder,et al.  A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge , 2011, Science Translational Medicine.

[74]  C. Broder,et al.  A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. , 2011, Vaccine.

[75]  P. Kwong,et al.  Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes , 2011, Journal of Virology.

[76]  C. Mandl,et al.  Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers , 2011, Proceedings of the National Academy of Sciences.

[77]  Benhur Lee,et al.  A Quantitative and Kinetic Fusion Protein-Triggering Assay Can Discern Distinct Steps in the Nipah Virus Membrane Fusion Cascade , 2010, Journal of Virology.

[78]  Herren Wu,et al.  Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion , 2010, Journal of Virology.

[79]  Vincent B. Chen,et al.  MolProbity: all-atom structure validation for macromolecular crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[80]  C. Broder,et al.  A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection , 2009, PLoS pathogens.

[81]  C. Broder,et al.  Preparation of Recombinant Viral Glycoproteins for Novel and Therapeutic Antibody Discovery , 2008, Methods in molecular biology.

[82]  C. Broder,et al.  A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats , 2008, Vaccine.

[83]  C. Broder,et al.  Exceptionally Potent Cross-Reactive Neutralization of Nipah and Hendra Viruses by a Human Monoclonal Antibody , 2008, The Journal of infectious diseases.

[84]  M. Georges-Courbot,et al.  Henipavirus and Tioman Virus Antibodies in Pteropodid Bats, Madagascar , 2007, Emerging infectious diseases.

[85]  C. Broder,et al.  Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine , 2006, Journal of Virology.

[86]  R. Lamb,et al.  Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation , 2006, Nature.

[87]  R. Dutch,et al.  Cathepsin L Is Involved in Proteolytic Processing of the Hendra Virus Fusion Protein , 2005, Journal of Virology.

[88]  H. Klenk,et al.  The Nipah Virus Fusion Protein Is Cleaved within the Endosomal Compartment* , 2005, Journal of Biological Chemistry.

[89]  Lin-Fa Wang,et al.  Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Oscar A. Negrete,et al.  EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus , 2005, Nature.

[91]  Anchi Cheng,et al.  Automated molecular microscopy: the new Leginon system. , 2005, Journal of structural biology.

[92]  R. Lamb,et al.  Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[93]  R. Dutch,et al.  Role of N-Linked Glycosylation of the Hendra Virus Fusion Protein , 2005, Journal of Virology.

[94]  C. Broder,et al.  Receptor Binding, Fusion Inhibition, and Induction of Cross-Reactive Neutralizing Antibodies by a Soluble G Glycoprotein of Hendra Virus , 2005, Journal of Virology.

[95]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[96]  R. Henderson,et al.  Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. , 2003, Journal of molecular biology.

[97]  David N. Mastronarde,et al.  SerialEM: A Program for Automated Tilt Series Acquisition on Tecnai Microscopes Using Prediction of Specimen Position , 2003, Microscopy and Microanalysis.

[98]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[99]  C. Broder,et al.  Hendra and Nipah viruses: different and dangerous , 2006, Nature Reviews Microbiology.